0001209191-22-036569.txt : 20220614 0001209191-22-036569.hdr.sgml : 20220614 20220614075109 ACCESSION NUMBER: 0001209191-22-036569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220614 DATE AS OF CHANGE: 20220614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Lynne Marie CENTRAL INDEX KEY: 0001727640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 221013455 MAIL ADDRESS: STREET 1: C/O SOLID BIOSCIENCES, LLC STREET 2: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-10 0 0001693011 Inozyme Pharma, Inc. INZY 0001727640 Sullivan Lynne Marie C/O INOZYME PHARMA, INC. 321 SUMMER STREET SUITE 400 BOSTON MA 02210 1 0 0 0 Stock Option (right to buy) 4.38 2022-06-10 4 A 0 9367 0.00 A 2032-06-09 Common Stock 9367 9367 D The option was granted on June 10, 2022. The shares underlying the option are scheduled to vest as to 100% of the shares on June 10, 2023, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date. /s/ Axel Bolte, as attorney-in-fact for Lynne Sullivan 2022-06-14